Renaissance Technologies’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.39M | Buy |
1,615,003
+426,050
| +36% | +$631K | ﹤0.01% | 2005 |
|
|
2025
Q1 | $3.04M | Buy |
1,188,953
+70,953
| +6% | +$182K | ﹤0.01% | 1731 |
|
|
2024
Q4 | $2.1M | Buy |
1,118,000
+162,100
| +17% | +$305K | ﹤0.01% | 2017 |
|
|
2024
Q3 | $975K | Buy |
955,900
+151,300
| +19% | +$154K | ﹤0.01% | 2459 |
|
|
2024
Q2 | $941K | Sell |
804,600
-20,100
| -2% | -$23.5K | ﹤0.01% | 2356 |
|
|
2024
Q1 | $1.04M | Buy |
824,700
+159,100
| +24% | +$200K | ﹤0.01% | 2463 |
|
|
2023
Q4 | $1.19M | Buy |
665,600
+44,500
| +7% | +$79.2K | ﹤0.01% | 2295 |
|
|
2023
Q3 | $1.03M | Sell |
621,100
-38,200
| -6% | -$63.4K | ﹤0.01% | 2273 |
|
|
2023
Q2 | $1.32M | Sell |
659,300
-550,450
| -46% | -$1.1M | ﹤0.01% | 2284 |
|
|
2023
Q1 | $2.54M | Buy |
1,209,750
+985,147
| +439% | +$2.07M | ﹤0.01% | 1878 |
|
|
2022
Q4 | $308K | Buy |
224,603
+107,403
| +92% | +$147K | ﹤0.01% | 3207 |
|
|
2022
Q3 | $122K | Buy |
117,200
+2,400
| +2% | +$2.5K | ﹤0.01% | 3531 |
|
|
2022
Q2 | $125K | Buy |
114,800
+102,900
| +865% | +$112K | ﹤0.01% | 3792 |
|
|
2022
Q1 | $13K | Buy |
+11,900
| New | +$13K | ﹤0.01% | 4019 |
|
|
2021
Q3 | – | Sell |
-30,075
| Closed | -$57K | – | 3756 |
|
|
2021
Q2 | $57K | Sell |
30,075
-477,559
| -94% | -$905K | ﹤0.01% | 3386 |
|
|
2021
Q1 | $2.26M | Buy |
507,634
+19,000
| +4% | +$84.7K | ﹤0.01% | 2138 |
|
|
2020
Q4 | $1.77M | Sell |
488,634
-1,700
| -0.3% | -$6.17K | ﹤0.01% | 2193 |
|
|
2020
Q3 | $1.9M | Sell |
490,334
-40,100
| -8% | -$155K | ﹤0.01% | 2168 |
|
|
2020
Q2 | $2.01M | Buy |
530,434
+53,000
| +11% | +$201K | ﹤0.01% | 2181 |
|
|
2020
Q1 | $1.12M | Buy |
477,434
+17,800
| +4% | +$41.8K | ﹤0.01% | 2373 |
|
|
2019
Q4 | $1.51M | Buy |
459,634
+14,587
| +3% | +$47.9K | ﹤0.01% | 2447 |
|
|
2019
Q3 | $913K | Buy |
445,047
+12,394
| +3% | +$25.4K | ﹤0.01% | 2641 |
|
|
2019
Q2 | $2.03M | Buy |
432,653
+30,882
| +8% | +$145K | ﹤0.01% | 2321 |
|
|
2019
Q1 | $1.77M | Buy |
401,771
+31,474
| +8% | +$139K | ﹤0.01% | 2374 |
|
|
2018
Q4 | $1.15M | Buy |
370,297
+43,657
| +13% | +$136K | ﹤0.01% | 2503 |
|
|
2018
Q3 | $2.37M | Buy |
326,640
+65,170
| +25% | +$474K | ﹤0.01% | 2194 |
|
|
2018
Q2 | $1.12M | Buy |
261,470
+30,520
| +13% | +$131K | ﹤0.01% | 2555 |
|
|
2018
Q1 | $1.25M | Buy |
230,950
+31,600
| +16% | +$171K | ﹤0.01% | 2564 |
|
|
2017
Q4 | $1.32M | Sell |
199,350
-10,780
| -5% | -$71.3K | ﹤0.01% | 2553 |
|
|
2017
Q3 | $1.22M | Sell |
210,130
-19,950
| -9% | -$116K | ﹤0.01% | 2501 |
|
|
2017
Q2 | $1.93M | Buy |
230,080
+37,330
| +19% | +$313K | ﹤0.01% | 2285 |
|
|
2017
Q1 | $2.62M | Buy |
192,750
+144,820
| +302% | +$1.97M | ﹤0.01% | 2093 |
|
|
2016
Q4 | $213K | Buy |
47,930
+29,840
| +165% | +$133K | ﹤0.01% | 2985 |
|
|
2016
Q3 | $103K | Buy |
18,090
+7,800
| +76% | +$44.4K | ﹤0.01% | 3175 |
|
|
2016
Q2 | $66K | Buy |
10,290
+4,800
| +87% | +$30.8K | ﹤0.01% | 3209 |
|
|
2016
Q1 | $46K | Buy |
5,490
+3,397
| +162% | +$28.5K | ﹤0.01% | 3286 |
|
|
2015
Q4 | $21K | Buy |
+2,093
| New | +$21K | ﹤0.01% | 3224 |
|